General Information of Drug (ID: DMRFBD0)

Drug Name
Deprenyl Drug Info
Synonyms
2323-36-6; CHEBI:50217; N,alpha-Dimethyl-N-2-propynylphenethylamine; N,alpha-Dimethyl-N-2-propynylbenzeneethanamine; methyl(1-phenylpropan-2-yl)(prop-2-yn-1-yl)amine; PHENETHYLAMINE, N,alpha-DIMETHYL-N-2-PROPYNYL-; N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine; dl-Deprenyl; phenylisopropyl-n-methylpropinylamine; AC1L1JT6; CHEMBL8663; SCHEMBL74753; cid_92913; 4-fluorodeprenyl, (-)-isomer; BDBM39862; MEZLKOACVSPNER-UHFFFAOYSA-N; HMS2089B08; AC1Q2862; MCULE-3188554308; ACM2323366
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
5195
ChEBI ID
CHEBI:50217
CAS Number
CAS 2323-36-6
TTD Drug ID
DMRFBD0

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Monoamine oxidase type B (MAO-B) TTGP7BY AOFB_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Monoamine oxidase type B (MAO-B) DTT MAOB 9.367 6.907 8.237 8.409
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Monoamine oxidase type B (MAO-B) DTT MAOB 2.65E-02 1.12E-02 0.07
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 The effect of deprenyl washout in patients with long-standing Parkinson's disease. J Neural Transm. 2002 May;109(5-6):797-803.